The European Society of Toxicology in Vitro (ESTIV) and the European Society for Alternatives to Animal Testing EUSAAT signed a Memorandum of Understanding at the EUSAAT 2022 congress in Linz. The MoU aims to intensify collaboration between the two EU societies with a focus on the implementation of 3Rs and New Approach Methodologies (NAMs) into modern science, research and regulations. More information on the collaboration between the two societies will be announced at the ESTIV 2022 Congress in Barcelona-Sitges.
Renewal of the ESTIV Board: Call for Applications
As is customary with any society, the terms of several board members are set to conclude after a certain time. We are now seeking new enthusiastic members who can join our team and help build upon the great work of our colleagues
👨🔬👩🔬 If you are passionate about promoting in vitro and in silico toxicology and contributing to the advancement of the field, we encourage you to apply!
The Latest in Liver Toxicity Assessment In Vitro
We’re excited to announce that registration is now open for the upcoming joint ASCCT-ESTIV webinar titled “The Latest in Liver Toxicity Assessment In Vitro,” which will feature presentations by Magnus Ingelman-Sundberg, PhD, BSc.Med from the Karolinska Institutet, and Mathieu Vinken, PhD, PharmD, ERT from Vrije Universiteit Brussel.
ESTIV Applied training course will be organised on May 29 – June 2 in Bratislava, Slovakia
The training course will be held in Bratislava, Slovakia, from May 29 to June 3, 2023. It is open to toxicologists, risk assessors, and other professionals interested in expanding their knowledge of #invitro and #insilico toxicology. Led by experts in the field, the course will provide you with hands-on training and practical experience that you can apply to your work. Don’t miss this opportunity to learn from the best in the field!